Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.2% |
| 2 | Healthcare | 13.65% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Consumer Staples | 11.26% |
| 5 | Industrials | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SMPL
1776
DELISTED
SIMPLICITY BANCORP INC
SMPL
| $1.91M | ﹤0.01% |
118,106
+3,406
| +3% | +$53.7K |
|
1777
KB Financial Group
KB
$42.1B
| $1.91M | ﹤0.01% |
47,100
-4,800
| -9% | -$181K |
|
|
TST
1778
DELISTED
TheStreet, Inc.
TST
| $1.9M | ﹤0.01% |
84,170
+9,102
| +12% | +$204K |
|
1779
Tetra Tech
TTEK
$9.35B
| $1.9M | ﹤0.01% |
338,625
-192,975
| -36% | -$1.04M |
|
1780
Radware
RDWR
$1.23B
| $1.89M | ﹤0.01% |
+105,200
| New | +$1.66M |
|
|
PEOP
1781
DELISTED
PEOPLES FED BANCSHARES INC COM STK (MD)
PEOP
| $1.89M | ﹤0.01% |
106,300
+3,900
| +4% | +$68.1K |
|
|
NCTY
1782
The9 Ltd
NCTY
$70M
| $1.87M | ﹤0.01% |
2,879
-65
| -2% | -$49.3K |
|
1783
Frequency Electronics
FEIM
$863M
| $1.87M | ﹤0.01% |
160,200
+1,800
| +1% | +$20.2K |
|
1784
Taoping
TAOP
$8.12M
| $1.86M | ﹤0.01% |
143
-8
| -5% | -$78K |
|
|
BVH
1785
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $1.86M | ﹤0.01% |
23,815
+5,780
| +32% | +$402K |
|
1786
AllianceBernstein
AB
$3.41B
| $1.85M | ﹤0.01% |
86,900
-237,600
| -73% | -$5.1M |
|
1787
Neogen
NEOG
$2.54B
| $1.85M | ﹤0.01% |
108,000
+24,000
| +29% | +$417K |
|
|
STEL
1788
DELISTED
STELLARONE CORPORATION COM
STEL
| $1.84M | ﹤0.01% |
76,600
+54,700
| +250% | +$1.31M |
|
1789
Huron Consulting
HURN
$2.42B
| $1.84M | ﹤0.01% |
29,358
-12,600
| -30% | -$737K |
|
|
ADEP
1790
DELISTED
Adept Technology Inc
ADEP
| $1.83M | ﹤0.01% |
108,600
+69,174
| +175% | +$706K |
|
1791
Urban One Class D
UONEK
$23.4M
| $1.83M | ﹤0.01% |
48,372
+25,432
| +111% | +$816K |
|
1792
Provident Financial Services
PFS
$3.21B
| $1.83M | ﹤0.01% |
94,823
-113,840
| -55% | -$2.1M |
|
|
CIS
1793
DELISTED
CAMELOT INFORMATION SYSTEMS INC ADS (EA RSTG 4 ORD)
CIS
| $1.83M | ﹤0.01% |
915,100
+61,665
| +7% | +$120K |
|
1794
Mannatech
MTEX
$12.1M
| $1.83M | ﹤0.01% |
107,860
+3,500
| +3% | +$77.2K |
|
1795
MGE Energy Inc
MGEE
$3.09B
| $1.82M | ﹤0.01% |
47,400
-5,100
| -10% | -$189K |
|
1796
LG Display
LPL
$3.5B
| $1.82M | ﹤0.01% |
150,200
+72,600
| +94% | +$833K |
|
|
ARRY
1797
DELISTED
Array Biopharma Inc
ARRY
| $1.82M | ﹤0.01% |
363,852
-222,900
| -38% | -$1.21M |
|
|
TNAV
1798
DELISTED
Telenav Inc.
TNAV
| $1.81M | ﹤0.01% |
274,800
-154,300
| -36% | -$1.03M |
|
1799
Agree Realty
ADC
$9.3B
| $1.8M | ﹤0.01% |
62,100
-1,100
| -2% | -$33.1K |
|
1800
DHT Holdings
DHT
$3.14B
| $1.8M | ﹤0.01% |
263,163
+102,500
| +64% | +$562K |
|
Similar funds
Jim Simons's Q4 2013 Portfolio in Review
As of Q4 2013, Jim Simons held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Pfizer worth $230M.
- Jim Simons's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Jim Simons added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Jim Simons's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Jim Simons fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Jim Simons's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Jim Simons opened 498 new positions and closed 464 in Q4 2013.
- Jim Simons's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.